Panavance Therapeutics Inc.
Pharmaceutical Manufacturing
1055 Westlakes Dr
4 employees
- Employees
- 4
- Contacts
- 1
- Emails
- 1
Panavance Therapeutics Inc. Overview
- Headquarters
- 1055 Westlakes Dr
- Website
- www.panavance.com
- Industry
- Pharmaceutical Manufacturing
- Employees
- 4
- Founded
- 2021
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
About Panavance Therapeutics Inc.
Panavance Therapeutics Inc. is a US, clinical-stage pharmaceutical company established in 2021 by the Swiss-based Avensis Pharma AG, a subsidiary of Ed. Geistlich Söhne AG für Chemische Industrie. Panavance is focused on advancing the development of GP-2250, a novel oncology therapeutic intended to improve outcomes and quality of life for patients with cancer. With its highly capable team and strong academic and industry partnerships, Panavance is pursuing a rigorous program to bring GP-2250 to patients around the world.
Panavance Therapeutics Inc. Contact Details
- People in AeroLeads
- 1
- With contact data
- 1
- Email contacts
- 1
- 100.0% coverage
Panavance Therapeutics Inc. Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Hanns Mohler | Prof. Em. and Director at Eth and University of Zurich | Zurich, Switzerland |
Email
|
Compare Similar Companies to Panavance Therapeutics Inc.
BioSpectra, Inc.
Pharmaceutical Manufacturing
Nutcracker Therapeutics
Biotechnology Research
Larimar Therapeutics Inc.
Biotechnology
Cognition Therapeutics, Inc.
Biotechnology Research
Uniquity Bio
Biotechnology Research
Kibow Biotech
Biotechnology Research
Autem Therapeutics
Biotechnology Research
Enalare Therapeutics Inc.
Pharmaceutical Manufacturing
SFA Therapeutics
Biotechnology
Alanis Therapeutics Inc.
Biotechnology Research